Moreover, it had been reported that ACAT1 is essential for the progression of ccRCC, but these studies only discussed the relationship between ACAT1 and prognosis, ignoring its important role in immunotherapy (Chen et al., 2019). The gene discussed is ACAT1; the disease is nonpapillary renal cell carcinoma.